Histogen Inc.
HSTODelisted Oct 12, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001383701
Histogen Inc. was delisted on Oct 12, 2023; its insiders filed their last Form 4 on Jun 21, 2023; 9 institutions reported holding it in 13F filings for Q3 2023, worth $9.53K in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Histogen Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 26 | 24 | −2 |
| Shares | 1.68M | 2.74M | +1.07M (+63.6%) |
| Value | $2.18M | $2.99M | +$808.6K (+37.1%) |
New holders (7)
Institutions that held Histogen Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| State Street Corp | 172,200 | $188.0K | 0.00% |
| Renaissance Technologies LLC | 92,721 | $101.0K | 0.00% |
| Natixis | 88,900 | $97.0K | 0.00% |
| Virtu Financial LLC | 63,471 | $69.0K | 0.01% |
| Goldman Sachs Group Inc | 31,344 | $34.0K | 0.00% |
| Salem Investment Counselors Inc | 20 | $0 | 0.00% |
| Royal Bank of Canada | 100 | $0 | 0.00% |
Sold out (9)
Institutions that held Histogen Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Acadian Asset Management LLC | 159,741 | $208.0K |
| Bank of New York Mellon Corp | 42,255 | $55.0K |
| Newman Dignan & Sheerar, Inc. | 32,522 | $42.0K |
| Curtis Advisory Group, LLC | 14,342 | $19.0K |
| Private Management Group Inc | 14,000 | $18.0K |
| Reilly Financial Advisors, LLC | 2,201 | $3.00K |
| The PNC Financial Services Group, Inc. | 1,461 | $2.00K |
| FMR LLC | 500 | $1.00K |
| Tower Research Capital LLC (TRC) | 100 | $0 |